Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology

Modern Pathology

Volumn 18, Issue 2, 2005, Pages 235-243

  Kansal, Rina ^a,b   Sait, Sheila N J ^b   Block, AnneMarie W ^b   Ward, Pamela M ^b   Kelly, Felicity L R ^b   Cheney, Richard T ^b   Czuczman, Myron ^b   Brecher, Martin L ^b   Barcos, Maurice ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

ALK; ALK positive B cell lymphoma; Anaplastic large cell lymphoma; Anaplastic lymphoma kinase; Fluorescence in situ hybridization; Trisomy 2

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE;

ANAPLASTIC CARCINOMA; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL LINEAGE; CHROMOSOME 2; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TRISOMY; TRISOMY 2; WORLD HEALTH ORGANIZATION;

ADULT; ANTIGENS, CD15; ANTIGENS, CD30; CA-15-3 ANTIGEN; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PROTEIN-TYROSINE KINASES; STATISTICS;

EID: 13244253707     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800299     Document Type: Article

References (36)

1. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-858.
2. Chan JKC, Ng CS, Hui PK, et al. Anaplastic large cell Ki-1 lymphoma: delineation of two morphological types. Histopathology 1989;15:11-34.
3. Kadin ME. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 1997;30:77-86.
4. Kinney MC, Collins RD, Greer JP, et al. A small cell predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 1993;17:859-868.
5. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large-cell lymphoma) CD30-Ki-1+ with a high content of reactive histiocytes. Histopathology 1990;16:383-391.
6. Chan JK, Buchanan R, Fletcher CD. Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. Am J Surg Pathol 1990;14:983-988.
7. Mann KP, Hall B, Kamino H, et al. Neutrophil-rich, Ki-1 positive anaplastic large cell malignant lymphoma. Am J Surg Pathol 1995;19:407-416.
8. Falini B, Liso A, Pasqualucci L, et al. CD30+ anaplastic large cell lymphoma, null type, with signet-ring appearance. Histopathology 1997;30:90-92.
9. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998;91:2076-2084.
10. Kinney MC, Kadin ME. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol 1999;111(Suppl 1):S56-S67.
11. Stein H, Foss H-D, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000;96:3681-3695.
12. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
13. Jaffe ES, Harris NL, Stein H, et al (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
14. Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct subgroup of T/null lymphomas ('ALK lymphomas') with a wide morphological spectrum. Am J Pathol 1998;153:875-886.
15. Gascoyne RD, Aoun P, Wu M, et al. Prognostic significance of anaplastic large cell lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999;93:3913-3921.
16. Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995;86:1954-1960.
17. Lennert K, Feller AC. Histopathology of Non-Hodgkin's Lymphomas, 2nd edn. Springer-Verlag: New York, 1992.
18. Haralambieva E, Pulford KA, Lamant L, et al. Anaplastic large cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. Br J Haematol 2000;109:584-591.
19. Delsol G, Lamant L, Mariamé B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 1997;89:1483-1490.
20. De Paepe P, Baens M, van Krieken H, et al. ALK activation by the CTLC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003;102:2638-2641.
21. Gascoyne RD, Lamant L, Martin-Subero JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of six cases. Blood 2003;102:2568-2573.
22. Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of two cases. Blood 2003;102:2642-2644.
23. Falini B, Pulford K, Pucciarini A, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999;94:3509-3515.
24. Touriol C, Greenland C, Lamant L, et al. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: two cases expressing ALK kinase fused to CTLC (clathrin chain polypeptide-like). Blood 2000;95:3204-3209.
25. Duyster J, Bai RY, Morris S. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 2001;20:5623-5637.
26. Kutok JL, Aster JC. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J Clin Oncol 2002;20:3691-3702.
27. Sundeen JT, Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent 'large cell lymphoma': histologic progression or composite malignancy? Am J Surg Pathol 1988;12:599-606.
28. Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease. In: Weiss LM (ed). Pathology of Lymph Nodes. Churchill Livingstone: Edinburgh, 1996, pp 215-228.
29. Mrózek K, Bloomfield CD. Major cytogenetic findings in non-Hodgkin's lymphoma. In: Cannelos GP, Lister TA and Sklar JL (eds). The Lymphomas. WB Saunders: Philadelphia, PA, 1998, pp 107-128.
30. Heim S, Mitelman F. Cancer Cytogenetics, 2nd edn. Alan R Liss: New York, 1995.
31. Trumper L, Pfreundschuh M, Bonin FV, et al. Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br J Haematol 1998;103:1138-1144.
32. Maes B, Vanhentenrijk V, Wlodarska I, et al. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol 2001;158:2185-2193.
33. Kuefer MU, Look AT, Pulford K, et al. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 1997;90:2901-2910.
34. Mitelman F, Johansson B, Mertens F (eds). Mitelman Database of Chromosome Aberrations in Cancer. Available at http://cgap.nci.nih.gov/Chromosomes/ Mitelman Accessed June 15, 2004.
35. Mao X, Orchard G, Lillington DM, et al. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. Genes Chromosomes Cancer 2003;37:176-185.
36. Zettl A, Rudiger T, Konrad M-A, et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004;164:1837-1848.